(PHEQ) Morgan Stanley Trust - Overview
Etf: Large-Cap, US, Equity, Index
Dividends
| Dividend Yield | 1.23% |
| Yield on Cost 5y | 1.64% |
| Yield CAGR 5y | -6.07% |
| Payout Consistency | 96.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 7.87% |
| Relative Tail Risk | 1.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -0.85 |
| Character TTM | |
|---|---|
| Beta | 0.566 |
| Beta Downside | 0.612 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.55% |
| CAGR/Max DD | 1.21 |
Description: PHEQ Morgan Stanley Trust December 16, 2025
The Morgan Stanley ETF Trust’s PHEQ aims to deliver capital appreciation by investing in U.S. large-cap equities that are constituents of the Solactive GBS U.S. 500 index at the time of purchase, effectively tracking a broad market exposure while being classified as an equity-hedged fund.
Key metrics to watch include its expense ratio (approximately 0.20% p.a.), total assets under management (~ $1.2 billion as of Q3 2024), and a dividend yield near 1.5%, which aligns with the underlying index’s performance. The fund’s return is closely tied to macro-drivers such as Federal Reserve policy, corporate earnings growth in the technology and consumer discretionary sectors, and overall U.S. GDP momentum.
For a deeper, data-driven dive into how PHEQ’s risk-adjusted performance stacks up against peers, you might explore ValueRay’s analytical tools.
What is the price of PHEQ shares?
Over the past week, the price has changed by +0.53%, over one month by -0.37%, over three months by +1.95% and over the past year by +9.35%.
Is PHEQ a buy, sell or hold?
What are the forecasts/targets for the PHEQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 35.4 | 8.3% |
PHEQ Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 136.8m USD (136.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 136.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 136.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.0% (E(136.8m)/V(136.8m) * Re(8.0%) + (debt-free company))
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)